| Shannon S Meyer, DPM | |
|
311 Elm St, Woodruff, WI 54568-9149 | |
| (715) 634-9023 | |
| (715) 634-9935 |
| Full Name | Shannon S Meyer |
|---|---|
| Gender | Female |
| Speciality | Podiatry |
| Experience | 29 Years |
| Location | 311 Elm St, Woodruff, Wisconsin |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316933542 | NPI | - | NPPES |
| 43222500 | Medicaid | WI | |
| CG4176 | Other | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213ES0103X | Podiatrist - Foot & Ankle Surgery | 726-25 (Wisconsin) | Secondary |
| 213E00000X | Podiatrist | 726-25 (Wisconsin) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Howard Young Medical Center | Woodruff, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Forest County Potawatomi Community | 3375454689 | 15 |
| Lac Courte Oreilles Governing Board | 7810983517 | 9 |
| Lac Du Flambeau Band Of Lake Superior Chippewa Indians | 5496707242 | 19 |
| Red Cliff Band Of Lake Superior Chippewa Indians | 4284537580 | 11 |
| Sokaogon Chippewa Community | 1759370869 | 8 |
| Bad River Band Of Lake Superior Tribe Of Chippewa Indians Wis | 7810089414 | 7 |
| Lac Vieux Desert Band Of Lake Superior Chippewa Indians | 2567629181 | 14 |
News Archive
Alticor and Metagenics today announced that they have entered into a joint venture agreement. Under the terms of the agreement, Alticor will obtain a substantial ownership interest in Metagenics, and the current Metagenics shareholders will continue to retain a significant interest in the company. The agreement is subject to customary closing conditions, including approval by Metagenics shareholders and antitrust clearance.
Sanford-Burnham scientists have identified the B and T Lymphocyte Attenuator (BTLA) inhibitory receptor as a key factor in limiting inflammatory responses, particularly in the skin. The study, published online today in Immunity, provides clarity on how T cells get fired up to protect against pathogens, and then cool down to restore immune homeostasis.
Admedus today announced it has received FDA clearance to market CardioCel in the US. CardioCel is the group's lead regenerative tissue product to repair and treat a range of cardiovascular and vascular defects. The Company will now look to complement its existing product launch in Europe with preparation for initial sales in the US.
Thomson Reuters Foundation today announces the launch of a pioneering, first-of-its-kind service - The Emergency Information Service (EIS). Developed to respond to major natural disasters around the world, the new EIS will deploy expert Action-Units of journalists to scenes of major catastrophe where they will seek out, collate and disseminate life-saving information to disaster-struck populations, filling a critical gap in the chain of crisis information.
Put on a happy face, your success may depend on it, suggests a study by psychology researchers at the University of Toronto's Faculty of Arts and Science.
› Verified 6 days ago
| Provider Name | Red Cliff Band Of Lake Superior Chippewa Indians |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1497744015 PECOS PAC ID: 4284537580 Enrollment ID: O20040202000406 |
News Archive
Alticor and Metagenics today announced that they have entered into a joint venture agreement. Under the terms of the agreement, Alticor will obtain a substantial ownership interest in Metagenics, and the current Metagenics shareholders will continue to retain a significant interest in the company. The agreement is subject to customary closing conditions, including approval by Metagenics shareholders and antitrust clearance.
Sanford-Burnham scientists have identified the B and T Lymphocyte Attenuator (BTLA) inhibitory receptor as a key factor in limiting inflammatory responses, particularly in the skin. The study, published online today in Immunity, provides clarity on how T cells get fired up to protect against pathogens, and then cool down to restore immune homeostasis.
Admedus today announced it has received FDA clearance to market CardioCel in the US. CardioCel is the group's lead regenerative tissue product to repair and treat a range of cardiovascular and vascular defects. The Company will now look to complement its existing product launch in Europe with preparation for initial sales in the US.
Thomson Reuters Foundation today announces the launch of a pioneering, first-of-its-kind service - The Emergency Information Service (EIS). Developed to respond to major natural disasters around the world, the new EIS will deploy expert Action-Units of journalists to scenes of major catastrophe where they will seek out, collate and disseminate life-saving information to disaster-struck populations, filling a critical gap in the chain of crisis information.
Put on a happy face, your success may depend on it, suggests a study by psychology researchers at the University of Toronto's Faculty of Arts and Science.
› Verified 6 days ago
| Provider Name | Forest County Potawatomi Community |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1285741306 PECOS PAC ID: 3375454689 Enrollment ID: O20040228000204 |
News Archive
Alticor and Metagenics today announced that they have entered into a joint venture agreement. Under the terms of the agreement, Alticor will obtain a substantial ownership interest in Metagenics, and the current Metagenics shareholders will continue to retain a significant interest in the company. The agreement is subject to customary closing conditions, including approval by Metagenics shareholders and antitrust clearance.
Sanford-Burnham scientists have identified the B and T Lymphocyte Attenuator (BTLA) inhibitory receptor as a key factor in limiting inflammatory responses, particularly in the skin. The study, published online today in Immunity, provides clarity on how T cells get fired up to protect against pathogens, and then cool down to restore immune homeostasis.
Admedus today announced it has received FDA clearance to market CardioCel in the US. CardioCel is the group's lead regenerative tissue product to repair and treat a range of cardiovascular and vascular defects. The Company will now look to complement its existing product launch in Europe with preparation for initial sales in the US.
Thomson Reuters Foundation today announces the launch of a pioneering, first-of-its-kind service - The Emergency Information Service (EIS). Developed to respond to major natural disasters around the world, the new EIS will deploy expert Action-Units of journalists to scenes of major catastrophe where they will seek out, collate and disseminate life-saving information to disaster-struck populations, filling a critical gap in the chain of crisis information.
Put on a happy face, your success may depend on it, suggests a study by psychology researchers at the University of Toronto's Faculty of Arts and Science.
› Verified 6 days ago
| Provider Name | Lac Courte Oreilles Governing Board |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1194830208 PECOS PAC ID: 7810983517 Enrollment ID: O20040420001318 |
News Archive
Alticor and Metagenics today announced that they have entered into a joint venture agreement. Under the terms of the agreement, Alticor will obtain a substantial ownership interest in Metagenics, and the current Metagenics shareholders will continue to retain a significant interest in the company. The agreement is subject to customary closing conditions, including approval by Metagenics shareholders and antitrust clearance.
Sanford-Burnham scientists have identified the B and T Lymphocyte Attenuator (BTLA) inhibitory receptor as a key factor in limiting inflammatory responses, particularly in the skin. The study, published online today in Immunity, provides clarity on how T cells get fired up to protect against pathogens, and then cool down to restore immune homeostasis.
Admedus today announced it has received FDA clearance to market CardioCel in the US. CardioCel is the group's lead regenerative tissue product to repair and treat a range of cardiovascular and vascular defects. The Company will now look to complement its existing product launch in Europe with preparation for initial sales in the US.
Thomson Reuters Foundation today announces the launch of a pioneering, first-of-its-kind service - The Emergency Information Service (EIS). Developed to respond to major natural disasters around the world, the new EIS will deploy expert Action-Units of journalists to scenes of major catastrophe where they will seek out, collate and disseminate life-saving information to disaster-struck populations, filling a critical gap in the chain of crisis information.
Put on a happy face, your success may depend on it, suggests a study by psychology researchers at the University of Toronto's Faculty of Arts and Science.
› Verified 6 days ago
| Provider Name | Sokaogon Chippewa Community |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1033115456 PECOS PAC ID: 1759370869 Enrollment ID: O20040512000238 |
News Archive
Alticor and Metagenics today announced that they have entered into a joint venture agreement. Under the terms of the agreement, Alticor will obtain a substantial ownership interest in Metagenics, and the current Metagenics shareholders will continue to retain a significant interest in the company. The agreement is subject to customary closing conditions, including approval by Metagenics shareholders and antitrust clearance.
Sanford-Burnham scientists have identified the B and T Lymphocyte Attenuator (BTLA) inhibitory receptor as a key factor in limiting inflammatory responses, particularly in the skin. The study, published online today in Immunity, provides clarity on how T cells get fired up to protect against pathogens, and then cool down to restore immune homeostasis.
Admedus today announced it has received FDA clearance to market CardioCel in the US. CardioCel is the group's lead regenerative tissue product to repair and treat a range of cardiovascular and vascular defects. The Company will now look to complement its existing product launch in Europe with preparation for initial sales in the US.
Thomson Reuters Foundation today announces the launch of a pioneering, first-of-its-kind service - The Emergency Information Service (EIS). Developed to respond to major natural disasters around the world, the new EIS will deploy expert Action-Units of journalists to scenes of major catastrophe where they will seek out, collate and disseminate life-saving information to disaster-struck populations, filling a critical gap in the chain of crisis information.
Put on a happy face, your success may depend on it, suggests a study by psychology researchers at the University of Toronto's Faculty of Arts and Science.
› Verified 6 days ago
| Provider Name | Comprehensive Foot & Ankle Sc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1346278959 PECOS PAC ID: 0446213706 Enrollment ID: O20041108000577 |
News Archive
Alticor and Metagenics today announced that they have entered into a joint venture agreement. Under the terms of the agreement, Alticor will obtain a substantial ownership interest in Metagenics, and the current Metagenics shareholders will continue to retain a significant interest in the company. The agreement is subject to customary closing conditions, including approval by Metagenics shareholders and antitrust clearance.
Sanford-Burnham scientists have identified the B and T Lymphocyte Attenuator (BTLA) inhibitory receptor as a key factor in limiting inflammatory responses, particularly in the skin. The study, published online today in Immunity, provides clarity on how T cells get fired up to protect against pathogens, and then cool down to restore immune homeostasis.
Admedus today announced it has received FDA clearance to market CardioCel in the US. CardioCel is the group's lead regenerative tissue product to repair and treat a range of cardiovascular and vascular defects. The Company will now look to complement its existing product launch in Europe with preparation for initial sales in the US.
Thomson Reuters Foundation today announces the launch of a pioneering, first-of-its-kind service - The Emergency Information Service (EIS). Developed to respond to major natural disasters around the world, the new EIS will deploy expert Action-Units of journalists to scenes of major catastrophe where they will seek out, collate and disseminate life-saving information to disaster-struck populations, filling a critical gap in the chain of crisis information.
Put on a happy face, your success may depend on it, suggests a study by psychology researchers at the University of Toronto's Faculty of Arts and Science.
› Verified 6 days ago
| Provider Name | Lac Du Flambeau Band Of Lake Superior Chippewa Indians |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1134235047 PECOS PAC ID: 5496707242 Enrollment ID: O20050221000179 |
News Archive
Alticor and Metagenics today announced that they have entered into a joint venture agreement. Under the terms of the agreement, Alticor will obtain a substantial ownership interest in Metagenics, and the current Metagenics shareholders will continue to retain a significant interest in the company. The agreement is subject to customary closing conditions, including approval by Metagenics shareholders and antitrust clearance.
Sanford-Burnham scientists have identified the B and T Lymphocyte Attenuator (BTLA) inhibitory receptor as a key factor in limiting inflammatory responses, particularly in the skin. The study, published online today in Immunity, provides clarity on how T cells get fired up to protect against pathogens, and then cool down to restore immune homeostasis.
Admedus today announced it has received FDA clearance to market CardioCel in the US. CardioCel is the group's lead regenerative tissue product to repair and treat a range of cardiovascular and vascular defects. The Company will now look to complement its existing product launch in Europe with preparation for initial sales in the US.
Thomson Reuters Foundation today announces the launch of a pioneering, first-of-its-kind service - The Emergency Information Service (EIS). Developed to respond to major natural disasters around the world, the new EIS will deploy expert Action-Units of journalists to scenes of major catastrophe where they will seek out, collate and disseminate life-saving information to disaster-struck populations, filling a critical gap in the chain of crisis information.
Put on a happy face, your success may depend on it, suggests a study by psychology researchers at the University of Toronto's Faculty of Arts and Science.
› Verified 6 days ago
| Provider Name | St. Croix Chippewa Indians Of Wi |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1831170091 PECOS PAC ID: 1153369350 Enrollment ID: O20050419000754 |
News Archive
Alticor and Metagenics today announced that they have entered into a joint venture agreement. Under the terms of the agreement, Alticor will obtain a substantial ownership interest in Metagenics, and the current Metagenics shareholders will continue to retain a significant interest in the company. The agreement is subject to customary closing conditions, including approval by Metagenics shareholders and antitrust clearance.
Sanford-Burnham scientists have identified the B and T Lymphocyte Attenuator (BTLA) inhibitory receptor as a key factor in limiting inflammatory responses, particularly in the skin. The study, published online today in Immunity, provides clarity on how T cells get fired up to protect against pathogens, and then cool down to restore immune homeostasis.
Admedus today announced it has received FDA clearance to market CardioCel in the US. CardioCel is the group's lead regenerative tissue product to repair and treat a range of cardiovascular and vascular defects. The Company will now look to complement its existing product launch in Europe with preparation for initial sales in the US.
Thomson Reuters Foundation today announces the launch of a pioneering, first-of-its-kind service - The Emergency Information Service (EIS). Developed to respond to major natural disasters around the world, the new EIS will deploy expert Action-Units of journalists to scenes of major catastrophe where they will seek out, collate and disseminate life-saving information to disaster-struck populations, filling a critical gap in the chain of crisis information.
Put on a happy face, your success may depend on it, suggests a study by psychology researchers at the University of Toronto's Faculty of Arts and Science.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Shannon S Meyer, DPM 7428 Loon Landing Shores, Lake Tomahawk, WI 54539-9110 Ph: (877) 265-5225 | Shannon S Meyer, DPM 311 Elm St, Woodruff, WI 54568-9149 Ph: (715) 634-9023 |
News Archive
Alticor and Metagenics today announced that they have entered into a joint venture agreement. Under the terms of the agreement, Alticor will obtain a substantial ownership interest in Metagenics, and the current Metagenics shareholders will continue to retain a significant interest in the company. The agreement is subject to customary closing conditions, including approval by Metagenics shareholders and antitrust clearance.
Sanford-Burnham scientists have identified the B and T Lymphocyte Attenuator (BTLA) inhibitory receptor as a key factor in limiting inflammatory responses, particularly in the skin. The study, published online today in Immunity, provides clarity on how T cells get fired up to protect against pathogens, and then cool down to restore immune homeostasis.
Admedus today announced it has received FDA clearance to market CardioCel in the US. CardioCel is the group's lead regenerative tissue product to repair and treat a range of cardiovascular and vascular defects. The Company will now look to complement its existing product launch in Europe with preparation for initial sales in the US.
Thomson Reuters Foundation today announces the launch of a pioneering, first-of-its-kind service - The Emergency Information Service (EIS). Developed to respond to major natural disasters around the world, the new EIS will deploy expert Action-Units of journalists to scenes of major catastrophe where they will seek out, collate and disseminate life-saving information to disaster-struck populations, filling a critical gap in the chain of crisis information.
Put on a happy face, your success may depend on it, suggests a study by psychology researchers at the University of Toronto's Faculty of Arts and Science.
› Verified 6 days ago
David C Larsen, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 311 Elm St, Woodruff, WI 54568 Phone: 715-634-9023 Fax: 715-634-9935 | |
Comprehensive Foot & Ankle, Sc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 311 Elm St, Woodruff, WI 54568 Phone: 877-265-5225 Fax: 715-277-4944 | |
Mindy Lee Wolf, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 728 Elm Street, Woodruff, WI 54568 Phone: 715-358-9777 Fax: 715-358-9737 | |
Achilles Foot And Ankle Clinic Sc Podiatrist Medicare: Medicare Enrolled Practice Location: 728 Elm Street, Woodruff, WI 54568 Phone: 715-358-9777 Fax: 715-358-9737 | |
Family Foot And Ankle Clinic Llc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 611 Veterans Pkwy, Woodruff, WI 54568 Phone: 715-241-8100 |